Last reviewed · How we verify

NCT03381872: RENOVATE

Intravascular Imaging- Versus Angiography-Guided Percutaneous Coronary Intervention For Complex Coronary Artery Disease

Active, enrolled NA Last updated 22 August 2025
What this trial tests

NA trial testing Percutaneous coronary intervention for complex lesion in Coronary Artery Disease in 1,639 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
10 May 2018
Primary endpoint
10 May 2022
31 December 2025

Quick facts

Lead sponsorSamsung Medical Center
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment1,639
Start date10 May 2018
Primary completion10 May 2022
Estimated completion31 December 2025
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Samsung Medical Center

Who can join

19 and older, any sex, with Coronary Artery Disease or Atherosclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to compare clinical outcomes between intravascular imaging-guided versus angiography-guided percutaneous coronary intervention (PCI) in complex lesions.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Intravascular Imaging-Guided or Angiography-Guided Complex PCI.
    Lee JM, Choi KH, Song YB, Lee JY, et al · · 2023 · cited 361× · PMID 36876735 · DOI 10.1056/nejmoa2216607
  2. Cost-Effectiveness of Intravascular Imaging-Guided Complex PCI: Prespecified Analysis of RENOVATE-COMPLEX-PCI Trial.
    Hong D, Lee J, Lee H, Cho J, et al · · 2024 · cited 17× · PMID 38477162 · DOI 10.1161/circoutcomes.123.010230
  3. Clinical Benefit of Intravascular Imaging Compared With Conventional Angiography in Left Main Coronary Artery Intervention.
    Kwon W, Lee JM, Yun KH, Choi KH, et al · · 2023 · cited 16× · PMID 38018841 · DOI 10.1161/circinterventions.123.013359
  4. Impact of Intravascular Imaging-Guided Stent Optimization According to Clinical Presentation in Patients Undergoing Complex PCI.
    Lee SY, Choi KH, Kim CJ, Lee JM, et al · · 2024 · cited 7× · PMID 38811104 · DOI 10.1016/j.jcin.2024.03.021
  5. Intravascular Imaging-Guided Percutaneous Coronary Intervention Before and After Standardized Optimization Protocols.
    Kwon W, Hong D, Choi KH, Lee SH, et al · · 2024 · cited 7× · PMID 38267144 · DOI 10.1016/j.jcin.2023.10.062
  6. Intravascular Imaging in Patients With Complex Coronary Lesions and Chronic Kidney Disease.
    Kwon W, Choi KH, Song YB, Park YH, et al · · 2023 · cited 7× · PMID 38019512 · DOI 10.1001/jamanetworkopen.2023.45554
  7. Intracoronary Imaging: Current Practice and Future Perspectives.
    Tsigkas G, Spyropoulou P, Bousoula E, Apostolos A, et al · · 2023 · cited 6× · PMID 39077408 · DOI 10.31083/j.rcm2402039
  8. Intravascular Imaging Predictors Associated With Cardiovascular Events After Complex PCIs.
    Lee JM, Lee SY, Kwon W, Lee SJ, et al · · 2025 · cited 4× · PMID 39965046 · DOI 10.1161/circinterventions.124.014920

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other Samsung Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03381872.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing